Overview

YiqiJiangzhuoHuoxueTongluo Method to Delay the Occurrence of End-stage Renal Disease in Diabetic Kidney Disease--Study2

Status:
NOT_YET_RECRUITING
Trial end date:
2028-07-31
Target enrollment:
Participant gender:
Summary
Using the practical randomized controlled trial designed by Zelen, the subjects were randomly divided into the experimental group and the control group. The experimental group was given the traditional Chinese medicine prescription ' Shenzhuo Decoction ' ( composed of Astragalus membranaceus, Salvia miltiorrhiza, Leech, Raw Rhubarb, Epimedium, Motherwort ) + basic treatment ( including nutrition, lifestyle, hypoglycemic, hypotensive, lipid-lowering, control of other risk factors, etc. ), the control group was given basic treatment, a total of 1 year of drug intervention, followed up for 1 year.
Phase:
NA
Details
Lead Sponsor:
Liu Hongfang
Collaborators:
EFONG PHARMRCEUTICRL
First Affiliated Hospital, Sun Yat-Sen University
Guang'anmen HospitalChina Academy of Chinese Medical Sciencescancel
The Affiliated Hospital to ChangChun University of Chinese Medicinecancel
Tianjin Medical University Chu Hsien-I Memorial Hospital
Treatments:
Control Groups